Michelle Cortez

Hi, it’s Michelle in Washington, where I spent yesterday trying to understand what President Trump’s executive order would mean for drug prices. More on that in a moment, but first ...

Greetings, it’s Michelle, coming to you now from Washington, DC. One of the last stories I wrote in Asia is also one of my favorites. It includes a colorful couple, a medical and regulatory breakthrough, internet fights and a catchy tune. More on that below, but first…

WuXi AppTec Co. told the US that its parent previously owned a company that was an early pioneer in widescale genetic sequencing, though it never had access to the data.

US intelligence officials told American lawmakers in February that the pharmaceutical firm WuXi AppTec Co. transferred a client’s intellectual property to Chinese authorities without permission, Reuters reported, citing unnamed sources.

Guidelines recommend against screening for most men over age 70

As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act, their experience in China, where such talks started almost a decade ago, could offer some insight into just how low costs may go.

Get everybody in an entire state to spit into a tube? You betcha.

The step-by-step protocols that doctors learn in medical school just weren’t stopping the new coronavirus from killing people.

Gene therapy Zolgensma is the world’s most expensive medicine. Here’s how parents are fighting to get it.

St. Jude researchers license technology to Mustang Bio in hopes of bringing treatment to market.